Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Journal of Cardiovascular Pharmacology|November 5, 2021
Human Angiopoietin-like Protein 3/ANGPTL3 Antibodies: Adding to the Armamentarium in the Management of DyslipidemiaBarbara S WigginsPharmacotherapy|April 7, 2022
Statin-associated muscle symptoms-A review: Individualizing the approach to optimize careBarbara S Wiggins, James M Backes, Daniel HillemanThe Journal of Innovations in Cardiac Rhythm Management|June 2, 2020
Postoperative Antibiotic Prophylaxis Following Cardiac Implantable Electronic Device PlacementGalen M Kabulski, Amanda Northup, Barbara S WigginsCurrent Atherosclerosis Reports|March 3, 2016
Gemfibrozil in Combination with Statins-Is It Really Contraindicated?Barbara S Wiggins, Joseph J Saseen, Pamela B MorrisPharmacotherapy|October 27, 2006
Role of P-glycoprotein in statin drug interactionsCarol W Holtzman, Barbara S Wiggins, Sarah A SpinlerThe Annals of Pharmacotherapy|August 19, 2007
Intraosseous drug administration in children and adults during cardiopulmonary resuscitationMarcia L Buck, Barbara S Wiggins, Jefferson M SeslerPharmacotherapy|February 6, 2016
Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant PhenytoinBarbara S Wiggins, Amanda Northup, Dominic Johnson, et al.Advances in Therapy|January 11, 2020
Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative ReviewDaniel E Hilleman, Barbara S Wiggins, Michael B BottorffAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 30, 2021
Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Weighing ≥ 120 Kilograms versus 60-120 KilogramsEryne E Wiethorn, Carolyn Magee Bell, Barbara S WigginsThe Annals of Pharmacotherapy|June 12, 2014
Cardiovascular Drug Shortages: Predominant Etiologies, Clinical Implications, and Management StrategiesBarbara S Wiggins, Jean Nappi, Christopher R Fortier, et al.Pageof 3